Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Eagle Pharmaceuticals and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/EGRX.
There is no cost or obligation to you.
New York, New York--(Newsfile Corp. - December 6, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals" or the "Company") (NASDAQ: EGRX).
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
On November 9, 2023, before the market opened, Eagle disclosed that it would not be able to file its quarterly report for the second quarter of 2023 on time because it required additional time to complete its review of potential adjustments relating to the reporting of sales of PEMFEXY.
On this news, Eagle's stock price fell $4.16, or 30.4%, to close at $9.54 per share on November 9, 2023, thereby injuring investors.
After the market closed on November 9, 2023, the Company also disclosed that it was reviewing potential adjustments to reserves for returns and price adjustments of approximately $15.0 million to $20.0 million relating to returns and a price adjustment for PEMFEXY stemming from slower-than-anticipated pull-through from a wholesale customer predominantly due to expiry of inventory.
On this news, Eagle's stock price fell $0.27, or 2.9%, to close at $9.27 per share on November 10, 2023.
Then, on November 29, 2023, Eagle disclosed that Scott Tarriff, the Company's President and Chief Executive Officer resigned and that the Company's board of directors accepted the resignation "[a]fter consideration of various alternatives, including termination with or without cause."
On this news, Eagle's stock price fell as much as 29% during intraday trading on November 29, 2023, thereby injuring investors further.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/189943